CORSAIR CAPITAL MANAGEMENT, L.P.

Position in LQDA — Liquidia Corp

CIK 1276470 NEW YORK, NY

Back to LQDA Full portfolio

Position in LQDA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$566,100

-$123,700 QoQ

Shares Held

15,000

-25.0% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CORSAIR CAPITAL MANAGEMENT, L.P. holds $2,460,103 across 5 Drug Manufacturers - Specialty & Generic names. LQDA ranks #2 (23.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HROW	Harrow, Inc.	19,000	$669,940
2	LQDA	Liquidia Corp This page	15,000	$566,100
3	ASRT	Assertio Holdings, Inc.	25,549	$486,963
4	RMTI	Rockwell Medical, Inc.	50,000	$446,600
5	AQST	Aquestive Therapeutics, Inc.	70,000	$290,500

All Filings in LQDA

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$566,100	15,000	-25.0%	Shares	Sole	2026-05-15
2025-12-31	$689,800	20,000	+100.0%	Shares	Sole	2026-02-17
2025-03-31	$147,500	10,000	—	Shares	Sole	2026-04-21
No filing history on record for this holder in this stock.